Takahashi N, Yoshizaki T, Hiranaka N, Kumano O, Suzuki T, Akanuma M, Yui T, Kanazawa K, Yoshida M, Naito S, Fujiya M, Kohgo Y, Ieko M
1] Department of Internal Medicine, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan [2] Department of Medicine, Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Asahikawa, Japan.
Department of Biotechnology, Faculty of Life Science and Biotechnology, Fukuyama University, Fukuyama, Japan.
Int J Obes (Lond). 2015 May;39(5):747-54. doi: 10.1038/ijo.2014.208. Epub 2014 Dec 15.
A relationship has been reported between blood concentrations of coagulation factor VII (FVII) and obesity. In addition to its role in coagulation, FVII has been shown to inhibit insulin signals in adipocytes. However, the production of FVII by adipocytes remains unclear.
We herein investigated the production and secretion of FVII by adipocytes, especially in relation to obesity-related conditions including adipose inflammation and sympathetic nerve activation.
C57Bl/6J mice were fed a low- or high-fat diet and the expression of FVII messenger RNA (mRNA) was then examined in adipose tissue. 3T3-L1 cells were used as an adipocyte model for in vitro experiments in which these cells were treated with tumor necrosis factor-α (TNF-α) or isoproterenol. The expression and secretion of FVII were assessed by quantitative real-time PCR, Western blotting and enzyme-linked immunosorbent assays.
The expression of FVII mRNA in the adipose tissue of mice fed with high-fat diet was significantly higher than that in mice fed with low-fat diet. Expression of the FVII gene and protein was induced during adipogenesis and maintained in mature adipocytes. The expression and secretion of FVII mRNA were increased in the culture medium of 3T3-L1 adipocytes treated with TNF-α, and these effects were blocked when these cells were exposed to inhibitors of mitogen-activated kinases or NF-κB activation. The β-adrenoceptor agonist isoproterenol stimulated the secretion of FVII from mature adipocytes via the cyclic AMP/protein kinase A pathway. Blockade of secreted FVII with the anti-FVII antibody did not affect the phosphorylation of Akt in the isoproterenol-stimulated adipocytes.
Obese adipose tissue produced FVII. The production and secretion of FVII by adipocytes was enhanced by TNF-α or isoproterenol via different mechanisms. These results indicate that FVII is an adipokine that plays an important role in the pathogenesis of obesity.
已有报道称凝血因子VII(FVII)的血药浓度与肥胖之间存在关联。除了在凝血中的作用外,FVII还被证明可抑制脂肪细胞中的胰岛素信号。然而,脂肪细胞产生FVII的情况仍不清楚。
我们在此研究了脂肪细胞中FVII的产生和分泌,特别是与肥胖相关状况(包括脂肪炎症和交感神经激活)的关系。
给C57Bl/6J小鼠喂食低脂或高脂饮食,然后检测脂肪组织中FVII信使核糖核酸(mRNA)的表达。3T3-L1细胞用作脂肪细胞模型进行体外实验,用肿瘤坏死因子-α(TNF-α)或异丙肾上腺素处理这些细胞。通过定量实时聚合酶链反应、蛋白质印迹法和酶联免疫吸附测定评估FVII的表达和分泌。
喂食高脂饮食的小鼠脂肪组织中FVII mRNA的表达显著高于喂食低脂饮食的小鼠。FVII基因和蛋白的表达在脂肪生成过程中被诱导,并在成熟脂肪细胞中维持。用TNF-α处理的3T3-L1脂肪细胞培养基中FVII mRNA的表达和分泌增加,当这些细胞暴露于丝裂原活化蛋白激酶或核因子-κB激活抑制剂时,这些作用被阻断。β-肾上腺素能受体激动剂异丙肾上腺素通过环磷酸腺苷/蛋白激酶A途径刺激成熟脂肪细胞分泌FVII。用抗FVII抗体阻断分泌的FVII对异丙肾上腺素刺激的脂肪细胞中Akt的磷酸化没有影响。
肥胖的脂肪组织产生FVII。TNF-α或异丙肾上腺素通过不同机制增强脂肪细胞中FVII的产生和分泌。这些结果表明FVII是一种脂肪因子,在肥胖发病机制中起重要作用。